Cite
HARVARD Citation
Ng, H. et al. (2020). Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma. Journal for immunotherapy of cancer. 8 (2), p. . [Online].